AndreaBozzo/ceres-open-data-index huggingface dataset:
Number of Drug and Alcohol-Related Intoxication Deaths by Place of Occurrence, 2007-2016[1][2]

This dataset is deprecated and will be removed by the end of the calendar year 2024. Updated on 8/18/2024

Drug and alcohol-related Intoxication death data is prepared using drug and alcohol intoxication data housed in a registry developed and maintained by the Vital Statistics Administration (VSA) of the Maryland Department of Health and Mental Hygiene (DHMH). The methodology for reporting on drug-related intoxication deaths in Maryland was developed by VSA with assistance from the DHMH Alcohol and Drug Abuse Administration, the Office of the Chief Medical Examiner (OCME) and the Maryland Poison Control Center. Assistance was also provided by authors of a 2008 Baltimore City Health Department report on intoxication deaths. Data in this table is by incident location, where the death occurred, rather than by county of residence.
Compound 525628: N,N-Dimethyl-N'-heptyl-p-methoxybenzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-heptyl-4-methoxy-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C17H28N2O. Molecular Weight: 276.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
IT Modernization and Agile Processes

How can the agile software development process be extended to procurement and contracting?

In an effort to replace its aging statewide child welfare information system, the State of California is making the transition to an agile software development approach. To support this effort, the State will no longer issue the traditional single, large request for proposal (RFP) for a monolithic system procurement. Instead, with the goal of saving time and money, the State has chosen to use an agile procurement approach by issuing a series of smaller RFPs to promote modular, sequential development. The State developed this new approach with the assistance of the Administration of Children, Youth, and Families (ACYF) and 18F, the innovative consulting arm of the General Services Administration (GSA). The State has already released two fast-track RFPs with contract awards expected in April or May.

Rafael López, ACYF commissioner, and other Federal personnel will discuss the advantages and opportunities provided through this new approach to how systems are procured. California staff will provide an overview of what is happening as they move forward with their IT modernization using this agile procurement approach.

Speakers presenting at this webinar include the following:

Metadata-only record linking to the original dataset. Open original dataset below.
CCWIS Cost Allocation Part 1

This DSS presentation is the first in a two-part series on CCWIS cost allocation and the difference between CCWIS and non-CCWIS cost allocation. It provides an overview of cost allocation and CCWIS Technical Bulletin #5. The webinar also explains the CCWIS Automated Function Checklist and its use for cost allocation.

Metadata-only record linking to the original dataset. Open original dataset below.
New Hampshire (NH)

This report presents New Hampshire\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for New Hampshire for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Runaway and Homeless Youth Management Information System (1992-1995)

It is estimated that over a million young people run away or become homeless each year.  These youth face increasingly complex issues, including substance abuse, physical and sexual abuse, and AIDS.  The serious issues faced by these youths are coupled with funding constraints among almost all agencies providing services to this population.  In 1974 the Family and Youth Services Bureau (FYSB) authorized funding to assist community based programs to serve youth who were not otherwise being served by traditional human service agencies. The funding was used for the operation of basic center programs which would provide support for runaway and homeless youth (RHY).  The programs offered emergency shelter, crisis intervention services, and family reunification services.   In 1988 the Transitional Living Program was introduced in order to provide services to older youth requiring assistance in becoming self-sufficient. While helping to support at-risk youth, the FYSB laws also mandate that certain data be regularly collected and reported. For example, FYSB supported agencies must report on the profile of the youth and families they serve, and provide an overview of the services which they deliver under their grant programs.  In order to assist these grantees in their reporting responsibilities, FYSB funded the development of a Runaway and Homeless Youth Management Information System (RHY MIS).   The RHY MIS was designed to provide comprehensive information on youth served, services provided, and programs which provide the services.The RHY MIS was designed, developed, and implemented by Information Technology International (ITI). Gradual implementation of the MIS began in 1992 with approximately 400 RHY grantee sites across the country. By 1995, virtually all existing grant programs had at least one staff member who had been trained and grantees were expected to use the MIS and submit data to FYSB on a quarterly basis.The fiscal year 1992-1995 RHY MIS dataset contains data submitted during the federal fiscal years 1992-1995.  Data are included from participating agencies in 53 US States and Territories.  The dataset includes one file which contains 93389 observations and 490 variables.  Variables pertaining to youth demographics, problems and services are provided.

Investigators: Diepenbrock, Elaine
Compound 525614: N,N-Dimethyl-N'-butyl-benzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-butyl-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C13H20N2. Molecular Weight: 204.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525776: 5-Ethyl-2,4-dimethyloxazole

Chemical compound data from PubChem database. IUPAC Name: 5-ethyl-2,4-dimethyl-1,3-oxazole. Molecular Formula: C7H11NO. Molecular Weight: 125.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530788: 3-Bromobenzoic acid, 3,5-difluorophenyl ester

Chemical compound data from PubChem database. IUPAC Name: (3,5-difluorophenyl) 3-bromobenzoate. Molecular Formula: C13H7BrF2O2. Molecular Weight: 313.09. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) in California Hospitals

California Health and Safety Code section 1288.55(a)(1) requires general acute care hospitals to report all cases of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) identified in their facilities to the California Department of Public Health (CDPH). MRSA BSI data are submitted by hospitals to the Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN). 

CDPH downloads California hospital MRSA BSI data from NHSN and analyzes the data to describe prevention progress in an annual public report of healthcare-associated infections. CDPH publishes annual MRSA BSI data reported by each California hospital in the datasets below. 

The following datasets include the number of MRSA BSI reported by each California hospital in the specified reporting year. Beginning in 2016 for each California hospital, the annual MRSA BSI dataset includes the number of MRSA BSI that were predicted to occur in each hospital based on its specific facility-level characteristics. The observed (reported) number of MRSA BSI are then compared to the predicted number of MRSA BSI in a ratio called the Standardized Infection Ratio or SIR. The SIR is a metric that summarizes an individual hospital’s MRSA BSI prevention progress compared with the national baseline and California state-specific prevention goals. 

The datasets also include the associated 95% confidence intervals for the SIR and statistical interpretation to show whether MRSA BSI incidence was the same (no different), better (lower) or worse (higher) than the national baseline. Another performance measure in this dataset allows for tracking hospital progress in meeting national HAI reduction goals. Hospitals must have an SIR at or below incremental targets each year to be considered on track.

Detailed information about the variables included in each dataset are described in the accompanying data dictionaries for the year of interest.

For more information about the SIR and NHSN’s statistical models that are used to calculate the predicted number of MRSA BSI for each hospital, please review “NHSN’s Guide to the SIR”: https://www.cdc.gov/nhsn/ps-analysis-resources/index.html 

For general information about NHSN, surveillance definitions, and reporting requirements for MRSA BSI, please visit: https://www.cdc.gov/nhsn/index.html 

To link the CDPH facility IDs with those from other Departments, including HCAI, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk.

For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/AnnualHAIReports.aspx
Results from the 2015 National Survey on Drug Use and Health:  Detailed Tables

Results from the 2015 National Survey on Drug Use and Health: Detailed Tables is a collection of tables presenting national estimates from the National Survey on Drug Use and Health (NSDUH). These tables present information on drug, alcohol, and tobacco use, as well as drug and alcohol dependence and abuse and treatment, and measures of mental health, such as major depressive episodes and serious mental illness. Measures of these behaviors and characteristics are presented by a variety of demographic, geographic, and other variables. The estimates in the tables include rates of the behaviors, numbers of persons engaging in these behaviors, and other measures. Although the majority of these tables are trend tables presenting estimates from the 2014 and 2015 NSDUHs, some tables include only estimates from the 2015 NSDUH.
Incidence Tables  (Prevalence Estimates) - 4.1 to 4.16

These detailed tables present totals and prevalence estimates of substance use initiation from the 2011 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants, sedatives, alcohol, and tobacco products (including cigarettes, smokeless tobacco, and cigars). Results are provided by age group and gender. Estimates are provided for both 2011 and 2010.
Compound 529726: 4aalpha,4bbeta-Gibbane-1alpha,10beta-dicarboxylic acid, 4a-hydroxy-1-methyl-8-methylene-, 1,4a-lactone, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate. Molecular Formula: C20H26O4. Molecular Weight: 330.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526139: Hexanoic acid, 2-propyl, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-propylhexanoate. Molecular Formula: C12H26O2Si. Molecular Weight: 230.42. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399973-T1: [Translated] HIGH-STRENGTH SURFACES FOR END-BALLISTIC PROTECTION AND WEAR PROTECTION AND METHOD FOR THE PRODUCTION THEREOF

The invention relates to the field of materials science and to high-strength planar structures for the protection of vehicles and people. The aim of the invention is to provide high-strength planar structures which are characterized in that the planar structure is only destroyed in the immediate vicinity of an impact. This aim is achieved by a high-strength planar structure that consists of individual elements that give, applied to a backing material, the high-strength planar structure. The individual elements have the shape of regular pyramids and tetrahedrons or irregular pentahedrons and/or hexahedrons and/or the individual elements consist of combined and interlinked shapes (compound shapes) of regular pyramids and tetrahedrons or irregular pentahedrons and/or hexahedrons. The aim is also achieved by a method which is characterized in that individual elements and/or shapes (compound shapes) combined from such individual elements and interlinked are combined to give a planar structure and are non-positively linked with a backing material at least on one side.
Patent AT-E400903-T1: [Translated] FUEL CELL SYSTEM WITH A DEVICE FOR SUPPLYING FUEL

A device (20) generates fuel like hydrogen and connects to a fuel feed (13) on its outlet side (22) and to a device (30) for feeding in fuel on its inlet side (21). The device for feeding in fuel has a twin-pump (34) in which an outlet material for fuel stored in a fuel tank (31) and water fed in via a feed pipe (38) are mixed into a fuel/water mixture stored in an intermediate tank (35) before being fed to the device for generating fuel.
Compound 527024: N-Methylfentanyl

Chemical compound data from PubChem database. IUPAC Name: N-(1-methylpiperidin-4-yl)-N-phenylpropanamide. Molecular Formula: C15H22N2O. Molecular Weight: 246.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Emergency Department Discharges (SPARCS De-Identified): Potentially Preventable Emergency Visit (PPV) Rates by Patient Zip Code: Beginning 2011

The datasets contain Potentially Preventable Visit (PPV) observed, expected, and risk-adjusted rates for all payer beneficiaries by patient county and patient zip code beginning in 2011. The Potentially Preventable Visits (PPV), obtained from software created by 3M Health Information Systems, are emergency visits that may result from a lack of adequate access to care or ambulatory care coordination.  These ambulatory sensitive conditions could be reduced or eliminated with adequate patient monitoring and follow up.
Massachusetts: 2011-2012 NSDUH

This report presents Massachusetts\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Technetium tc 99m sestamibi

Technetium Tc 99m Sestamibi is a radiopharmaceutical injectable drug used intravenously for diagnostic imaging, such as assessing heart function or detecting certain tumors. Manufactured by Curium US LLC, it contains Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate at 1 mg/mL strength. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E401407-T1: [Translated] METHOD FOR PRODUCING CYTOSINE NUCLEOSIDE COMPOUNDS

The invention provides a method for producing a cytosine nucleoside compound from pentose-1-phosphate and cytosine or a derivative thereof using a nucleoside phosphorylase reactive to cytosine or a bacterium having the enzyme activity. The invention also provides a method for specifically reducing an activity to degrade the substrates or the product, resulting in efficient production of the cytosine nucleoside compound. According to the invention, little by-product is produced in producing cytonucleocide compounds.
St. Louis, MO-IL

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the St. Louis, MO-IL metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the St. Louis metro area, Missouri, and the U.S. overall.
The Maltreatment of Children with Disabilities and Child Maltreatment in Substance Abusing Families, 1991

This study examines the incidence of substantiated maltreatment among children with cognitive, physical, emotional or learning disabilities, with specific attention given to the relationship between maltreatment and disabilities. It also investigates the incidence of child abuse and neglect among children in substance abusing families, and the relationship between child abuse and familial substance abuse.  The data were collected from a nationally representative group of 35 Child Protective Services (CPS) agencies, which were asked to provide information on all cases of substantiated maltreatment over a four to six week period in early 1991. The Archive distributes 5 data files for this study which provide information on a total of 1,249 substantiated maltreatment incidents.  A case-level data file includes demographic information on the children and adults involved in each case, information on the timing, type, and reporting of maltreatment, data on the relationships between the individuals involved in each case, and case status.  A second file contains caseworker assessments of  children with suspected or known disabilities, as well as information on the sources and reliability of those assessments.  An estimated 14.1 percent of the children in the study were identified by caseworkers as having one or more disabilities, using the definition found in the Americans with Disabilities Act (P.L. 101-336).  A third data file contains substance abuse information for each adult in the study suspected of substance abuse.  In addition to the three files mentioned above there are two files the which the Archive distributes which are restructured versions of the case-level file, in which the unit of analysis has been changed to represent an individual involved in a case.

Investigators: Ratnofsky, A., & Crosse, S.
Compound 526653: 7-Chloro-5-(2-fluorophenyl)-3-methyl-1,3-dihydro-1,4-benzodiazepin-2-one

Chemical compound data from PubChem database. IUPAC Name: 7-chloro-5-(2-fluorophenyl)-3-methyl-1,3-dihydro-1,4-benzodiazepin-2-one. Molecular Formula: C16H12ClFN2O. Molecular Weight: 302.73. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Table 4. Perceptions of Great Risk of Smoking Marijuana Once a Month, by Age Group and State: Percentages, Annual Averages Based on 2010 and 2011 NSDUHs

This report presents State estimates for measures of perceptions of great risk of smoking marijuana once a month based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Results are provided for youth aged 12 to 17.
Compound 526849: Acetic acid 4,5-dimethoxy-tetrahydro-pyran-3-yl ester

Chemical compound data from PubChem database. IUPAC Name: (4,5-dimethoxyoxan-3-yl) acetate. Molecular Formula: C9H16O5. Molecular Weight: 204.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
COVID-19 State Profile Report - District of Columbia

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
North Dakota: 2011-2012 NSDUH

This report presents North Dakota\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E401097-T1: [Translated] USE OF IMIDAZOCINOLINAMINES AS ADJUVANTS IN DNA VACCINATION

Chemical patent from PubChem database. Patent Number: AT-E401097-T1. Title: Novel Chemical Entity. Filing Date: 1996-04-28. Inventors: Martinez, Carlos, Thompson, Emily. Abstract: The invention relates to a novel chemical entity with unique structural features and biological properties, suitable for development as a therapeutic ... IPC Classifications: C12N, C12P, A61K. This patent covers 38 claims related to 8 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Compound 526942: 2-Methyl-3-thienyl 3-thienyl disulphide

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-(thiophen-3-yldisulfanyl)thiophene. Molecular Formula: C9H8S4. Molecular Weight: 244.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.